Immutep Limited (ASX:IMM)
Australia · Delayed Price · Currency is AUD 0.0750
+0.0030 (4.17%)
Apr 16, 2026, 4:11 PM AEST
Immutep Market Cap
Immutep has a market cap or net worth of 106.11 million as of April 16, 2026. Its market cap has decreased by -74.42% in one year.
Market Cap
106.11M
Enterprise Value
8.19M
Revenue
7.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 106.11M, an increase of 2,796.78%. That is a compound annual growth rate of 12.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 110.53M | -81.93% |
| Dec 31, 2025 | 611.59M | 15.11% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amplia Therapeutics | 79.53M |
| Botanix Pharmaceuticals | 77.63M |
| LTR Pharma | 72.71M |
| Radiopharm Theranostics | 70.88M |
| Cynata Therapeutics | 68.86M |
| Neurizon Therapeutics | 58.84M |
| Prescient Therapeutics | 54.68M |
| Imugene | 49.98M |